Canada Blood Transfusion Diagnostics Market Insight
Published: 01 June 2026 | Report Format: Electronic (PDF)
The Canada blood transfusion diagnostics market size is rapidly expanding, at a 7.49% CAGR, and the safe screening demand, chronic diseases, and lab automation.
Canada Blood Transfusion Diagnostics Market Insights Forecasts to 2035
- The Canada Blood Transfusion Diagnostics Market Size Was Estimated at USD 193.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.49% from 2025 to 2035
- The Canada Blood Transfusion Diagnostics Market Size is Expected to Reach USD 398.2 Million by 2035
Notable Insights for Canada Blood Transfusion Diagnostics Market
- Screening and testing systems for blood and infectious diseases have an estimated market share of around 39%, owing to the increased need for transfusion safety, fueled by over £3.8Billion in investments in molecular diagnostics, donor screening, and infection monitoring systems.
- Immunohematology analyzer systems have an estimated market share of around 33%, owing to the increased demand for lab automation, fueled by over £4.2Billion in investments in diagnostic technologies, haematology analysis systems, and blood compatibility testing.
- The healthcare industry in the United Kingdom makes annual investments in excess of £190Billion towards growth in the diagnosis of blood transfusion, fueled by investments of over £6Billion towards lab modernization, blood safety systems, and advanced screening techniques.
- Nucleic acid technology and molecular diagnostics have an estimated market share of around 28%, owing to the increased need for infectious disease detection and screening systems, fueled by over £5Billion in investments in genomic and precision testing techniques.
Download the eBook (ToC)
Why Buy This Report
- Get complete insights into the UK blood transfusion diagnostic market involving blood screening systems, molecular diagnostics, immunohematology analyzers, nucleic acid testing systems, and transfusion management systems.
- Learn about the impact of AI-enabled diagnostics, laboratory automation, genomics testing, digital pathology systems, and blood safety technologies on the Canada Blood Transfusion Diagnostics Market.
- Explore potential investment opportunities in infectious disease diagnostics, blood compatibility diagnostics, laboratory automation solutions, precise transfusion medicine, and intelligent healthcare analysis systems.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada blood transfusion diagnostics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Canada Blood Transfusion Diagnostics Market
-
- Grifols
- Bio-Rad Laboratories
- Abbott
- Roche
- Ortho Clinical Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- QuidelOrtho
- Others
Recent Developments:
- In March 2026, U.S.-based Bio-Rad Laboratories expanded diagnostics innovation with BioPlex 2200 and ddPLEX ESR1 technologies, supporting R&D investments exceeding USD 100 million, enhancing multiplex blood screening, precision disease monitoring, laboratory efficiency, and global molecular diagnostics market growth.
- In April 2026, Spain-based Grifols advanced diagnostics and immunohematology through sCD38 solutions and automation robotics alliances, supporting investments exceeding USD 500 million, improving pre-transfusion compatibility testing for multiple myeloma patients, and strengthening global transfusion medicine efficiency and precision healthcare markets.
Market Segmentation:
Canada Blood Transfusion Diagnostics Market, By Product Type
- Reagents & Kits
- Instruments
- Software & Services
- Others
Canada Blood Transfusion Diagnostics Market, By Technology
- Molecular Diagnostics
- Immunohematology
- Nucleic Acid Testing
- Blood Typing
- Cross-Matching Technologies
- Others
Canada Blood Transfusion Diagnostics Market, By Application
- Blood Screening
- Infectious Disease Testing
- Compatibility Testing
- Donor Screening
- Others
Canada Blood Transfusion Diagnostics Market, By End User
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Research Institutes
- Others
Expert Views:
The Canada Blood Transfusion Diagnostics Market is expected to show significant growth in the coming years due to growing demand for transfusion safety tools, higher investment in lab automation, and growing usage of molecular diagnostics systems. Experts in the industry suggest that platforms for nucleic acid testing, laboratory analytics powered by AI, automated immunohematology tools, genomics-based blood screening tools, digital transfusion management systems.
Author: Govind and Krishna By Spherical Insights and Consulting